Specifically, we hypothesized that PDH inhibition or PDHA1 knockdown might play a role in EMT and chemoresistance and investigated how disruption of PDH activity influenced the molecular events triggering these changes using lung cancer cells as a model. This evidence concerns the gene PDHA1 and lung cancer.